Fentanyl (FTY) Rapid Test
Place of Origin:China
Brand Name:HIRIKON
Power Source:Manual
Warranty:2 Year
After-sale Service:Online technical support
Material:Plastic
Shelf Life:2years
Quality Certification:ce
Instrument classification:Class II
Safety standard:None
Name:Fentanyl (FTY) Rapid Test
Application:Hospital Clinic
Storage Temperature:4℃ ~ 30℃, Do Not Refrigerate
Specimen:Urine
OEM/ODM:Available
Certificated:CE
Home Health Care Diagnostics test Fentanyl (FYL/ FTY) TEST
Intended Use
Fentanyl (FTY) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Fentanyl (FTY) listed in the table below.
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to the Fentanyl (FTY) abuse test result, particularly when preliminary positive results are indicated.
Test Principle
Fentanyl (FTY) Rapid Test is a competitive immunoassay that is used to screen for the presence of Fentanyl (FTY) and metabolites in urine. It is a chromatographic absorbent device in which, drugs within a urine sample, are competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into the test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When the drug within the urine sample is below the detection level of the test, the respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored test line in the Test Region (T) of the Test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free the drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device.
This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of the Test, if the test has been performed properly.
OPERATION
Test must be in room temperature (15ºC to 30ºC)
1. Donor collects urine specimen in a urine cup.
2. Open the sealed pouch by tearing along the notch. Remove the test from the pouch and place it on a level surface.
3. Hold the sample dropper vertically, and add exactly three drops of the urine specimen into the sample well.
4. The result should be read at 5 minutes.
Reviews
There are no reviews yet.